Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial

BACKGROUND: Up to 30% of patients with schizophrenia are resistant to antipsychotic drug treatment, with 60% of such cases also failing to respond to clozapine. Deep brain stimulation (DBS) has been used in treatment resistant patients with other psychiatric disorders, but there is a lack of trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Corripio, Iluminada, Roldán, Alexandra, Sarró, Salvador, McKenna, Peter J., Alonso-Solís, Anna, Rabella, Mireia, Díaz, Anna, Puigdemont, Dolors, Pérez-Solà, Víctor, Álvarez, Enric, Arévalo, Antonio, Padilla, Pedro P., Ruiz-Idiago, Jesus M., Rodríguez, Rodrigo, Molet, Joan, Pomarol-Clotet, Edith, Portella, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953640/
https://www.ncbi.nlm.nih.gov/pubmed/31927311
http://dx.doi.org/10.1016/j.ebiom.2019.11.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953640/
https://www.ncbi.nlm.nih.gov/pubmed/31927311
http://dx.doi.org/10.1016/j.ebiom.2019.11.029

Ejemplares similares